Management to host conference call today at 4:30 p.m. ET LEXINGTON, Mass., May 12, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today reported its...
Hence then, the article about curis provides first quarter 2026 business update was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Curis Provides First Quarter 2026 Business Update )
Also on site :
- ‘American Idol’ Alum Ruben Studdard Stuns Fans With Weight-Loss Transformation After Hitting 462 Pounds
- Ted Lasso's Lady Greyhounds Unpack Gemma's Head-Versus-Heart Dilemma, Lizzie's Life Beyond Motherhood, And What's Holding Boots Back
- Ella Langley Reveals Her Dream Collaborations—Including One With the ‘Queen of Rock and Roll’